CD24Fc

Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate
Biopharma Reporter
Mon, 11/23/20 - 10:43 am
Merck
OncoImmune
M&A
CD24Fc
COVID-19
OncoImmune nabs $56M round for late-stage COVID-19 tests, leukemia treatment
Fierce Biotech
Wed, 09/9/20 - 10:57 am
OncoImmune
COVID-19
leukemia
CD24Fc
OncoImmune receives FDA approval for COVID-19 clinical trial
Pharmaceutical Business Review
Thu, 04/9/20 - 10:29 am
OncoImmune
FDA
clincial trials
CD24Fc
COVID-19